ArticleJournal of cheminformatics2025
SGEDiff: a subgraph-enriched diffusion model for structure-based 3D molecular generation.
Article in Journal of cheminformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Structure-based molecular generation is an emerging approach in computer-aided drug discovery, enabling the design of compounds that that complement the three-dimensional structure of target proteins. However, most diffusion-based 3D molecular generative models still face several limitations, such as imbalanced protein-ligand representations or reliance on predefined binding pockets. To address these limitations, we propose SGEDiff, a novel subgraph enriched generative framework for 3D molecule generation. Our model hierarchically fuses subgraph and global graph representations to capture both local binding patterns and key structural features of protein pockets. Furthermore, an integrated pocket prediction module identifies binding regions in unseen proteins, eliminating reliance on predefined pocket coordinates. Experimental results show that SGEDiff outperforms baseline diffusion-based methods in generating high-affinity molecules across diverse targets. Moreover, practical applications in de novo drug design demonstrate improved success rates in generating compounds for novel protein targets, underscoring its potential to advance structure-based drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.